ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation
NACompletedINTERVENTIONAL
Enrollment
140
Participants
Timeline
Start Date
January 8, 2018
Primary Completion Date
March 31, 2021
Study Completion Date
March 31, 2021
Conditions
Atrial Fibrillation
Interventions
DEVICE
ECG-I mapping and PVI
ECG-I mapping and PVI
Trial Locations (1)
EC1A 7BE
Barts Heart Centre, London
All Listed Sponsors
lead
Barts & The London NHS Trust
OTHER
NCT03394404 - ECG-I Phenotyping of Persistent AF Based on Driver Distribution to Predict Response to Pulmonary Vein Isolation | Biotech Hunter | Biotech Hunter